Participant flow16

How many started, completed or left each group, period by period.

1 to 16 of 16

Period	Milestone	Group	Participants
Overall Study	STARTED	Ataluren	120
Overall Study	STARTED	Placebo	118
Overall Study	Completed Week 16	Ataluren	107
Overall Study	Completed Week 16	Placebo	113
Overall Study	Completed Week 24	Ataluren	103
Overall Study	Completed Week 24	Placebo	110
Overall Study	As-Treated Population*	Ataluren	120
Overall Study	As-Treated Population*	Placebo	118
Overall Study	ITT Population	Ataluren	116
Overall Study	ITT Population	Placebo	116
Overall Study	Per Protocol Population	Ataluren	100
Overall Study	Per Protocol Population	Placebo	103
Overall Study	COMPLETED	Ataluren	100
Overall Study	COMPLETED	Placebo	104
Overall Study	NOT COMPLETED	Ataluren	20
Overall Study	NOT COMPLETED	Placebo	14

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00803205/flow